Cargando…
Autoimmune Skin Disease Exacerbations Following COVID-19 Vaccination
BACKGROUND: Vaccination against COVID-19 reduces the risk of severe COVID-19 disease and death. However, few studies have examined the safety of the COVID-19 vaccine in patients with autoimmune skin disease. OBJECTIVES: We sought to determine the incidence of disease exacerbation in this population...
Autores principales: | Sprow, Grant, Afarideh, Mohsen, Dan, Joshua, Feng, Rui, Keyes, Emily, Grinnell, Madison, Concha, Josef, Werth, Victoria P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186119/ https://www.ncbi.nlm.nih.gov/pubmed/35693768 http://dx.doi.org/10.3389/fimmu.2022.899526 |
Ejemplares similares
-
260 Responses following COVID-19 vaccination in patients with autoimmune skin disease
por: Sprow, G., et al.
Publicado: (2022) -
Bullous systemic lupus erythematosus in females
por: Sprow, Grant, et al.
Publicado: (2022) -
Sclerotic skin disease development following COVID-19 vaccination
por: Sprow, Grant, et al.
Publicado: (2022) -
Dermatomyositis associated with hyponatremia and anasarca
por: Grinnell, Madison, et al.
Publicado: (2021) -
Comparing dermatologic patient-reported outcome measures in cutaneous lupus erythematosus
por: Sprow, Grant, et al.
Publicado: (2022)